281 related articles for article (PubMed ID: 30552058)
1. Early onset children's interstitial lung diseases: Discrete entities or manifestations of pulmonary dysmaturity?
Bush A; Griese M; Seidl E; Kerem E; Reu S; Nicholson AG
Paediatr Respir Rev; 2019 Apr; 30():65-71. PubMed ID: 30552058
[TBL] [Abstract][Full Text] [Related]
2. Exacerbations in neuroendocrine cell hyperplasia of infancy are characterized by increased air trapping.
Houin PR; Deterding RR; Young LR
Pediatr Pulmonol; 2016 Mar; 51(3):E9-12. PubMed ID: 26642007
[TBL] [Abstract][Full Text] [Related]
3. Interstitial lung disease in infancy.
Bush A; Gilbert C; Gregory J; Nicholson AG; Semple T; Pabary R
Early Hum Dev; 2020 Nov; 150():105186. PubMed ID: 32958330
[TBL] [Abstract][Full Text] [Related]
4. Role of High-Resolution Chest Computed Tomography in a Child with Persistent Tachypnoea and Intercostal Retractions: A Case Report of Neuroendocrine Cell Hyperplasia.
Lelii M; Patria MF; Pinzani R; Tenconi R; Mori A; Bonelli N; Principi N; Esposito S
Int J Environ Res Public Health; 2017 Sep; 14(10):. PubMed ID: 28946688
[No Abstract] [Full Text] [Related]
5. Bombesin staining in neuroendocrine cell hyperplasia of infancy (NEHI) and other childhood interstitial lung diseases (chILD).
Yancheva SG; Velani A; Rice A; Montero A; Hansell DM; Koo S; Thia L; Bush A; Nicholson AG
Histopathology; 2015 Oct; 67(4):501-8. PubMed ID: 25684686
[TBL] [Abstract][Full Text] [Related]
6. Persistent Tachypnea of Infancy. Usual and Aberrant.
Rauch D; Wetzke M; Reu S; Wesselak W; Schams A; Hengst M; Kammer B; Ley-Zaporozhan J; Kappler M; Proesmans M; Lange J; Escribano A; Kerem E; Ahrens F; Brasch F; Schwerk N; Griese M;
Am J Respir Crit Care Med; 2016 Feb; 193(4):438-47. PubMed ID: 26474448
[TBL] [Abstract][Full Text] [Related]
7. Interstitial Lung Disease in Children: "Specific Conditions of Undefined Etiology" Becoming Clearer.
Presti S; Parisi GF; Papale M; Gitto E; Manti S; Leonardi S
Children (Basel); 2022 Nov; 9(11):. PubMed ID: 36421193
[TBL] [Abstract][Full Text] [Related]
8. Abnormal infant pulmonary function in young children with neuroendocrine cell hyperplasia of infancy.
Kerby GS; Wagner BD; Popler J; Hay TC; Kopecky C; Wilcox SL; Quinones RR; Giller RH; Accurso FJ; Deterding RR
Pediatr Pulmonol; 2013 Oct; 48(10):1008-15. PubMed ID: 23169677
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary interstitial glycogenosis associated with a spectrum of neonatal pulmonary disorders.
Cutz E; Chami R; Dell S; Langer J; Manson D
Hum Pathol; 2017 Oct; 68():154-165. PubMed ID: 28873355
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine Cell Hyperplasia of Infancy. Clinical Score and Comorbidities.
Liptzin DR; Pickett K; Brinton JT; Agarwal A; Fishman MP; Casey A; Towe CT; Taylor JB; Kurland G; Hagood JS; Wambach J; Srivastava R; Al-Saleh H; Dell SD; Young LR; Deterding RR
Ann Am Thorac Soc; 2020 Jun; 17(6):724-728. PubMed ID: 32109152
[No Abstract] [Full Text] [Related]
11. Ground-glass burden as a biomarker in neuroendocrine cell hyperplasia of infancy.
Spielberg DR; Brody AS; Baker ML; Woods JC; Towe CT
Pediatr Pulmonol; 2019 Jun; 54(6):822-827. PubMed ID: 30843378
[TBL] [Abstract][Full Text] [Related]
12. Familial neuroendocrine cell hyperplasia of infancy.
Popler J; Gower WA; Mogayzel PJ; Nogee LM; Langston C; Wilson AC; Hay TC; Deterding RR
Pediatr Pulmonol; 2010 Aug; 45(8):749-55. PubMed ID: 20623780
[TBL] [Abstract][Full Text] [Related]
13. Serum KL-6 differentiates neuroendocrine cell hyperplasia of infancy from the inborn errors of surfactant metabolism.
Doan ML; Elidemir O; Dishop MK; Zhang H; Smith EO; Black PG; Deterding RR; Roberts DM; Al-Salmi QA; Fan LL
Thorax; 2009 Aug; 64(8):677-81. PubMed ID: 19237389
[TBL] [Abstract][Full Text] [Related]
14. Lung and airway shape in neuroendocrine cell hyperplasia of infancy.
Mastej EJ; DeBoer EM; Humphries SM; Cook MC; Hunter KS; Liptzin DR; Weinman JP; Deterding RR
Pediatr Radiol; 2018 Nov; 48(12):1745-1754. PubMed ID: 29955904
[TBL] [Abstract][Full Text] [Related]
15. Sleeping chILD: Neuroendocrine cell hyperplasia of infancy and polysomnography.
Liptzin DR; Hawkins SMM; Wagner BD; Deterding RR
Pediatr Pulmonol; 2018 Jul; 53(7):917-920. PubMed ID: 29766677
[TBL] [Abstract][Full Text] [Related]
16. Variation in the bombesin staining of pulmonary neuroendocrine cells in pediatric pulmonary disorders-A useful marker for airway maturity.
Emiralioğlu N; Orhan D; Cinel G; Tuğcu GD; Yalçın E; Doğru D; Özçelik U; Griese M; Kiper N
Pediatr Pulmonol; 2020 Sep; 55(9):2383-2388. PubMed ID: 32558323
[TBL] [Abstract][Full Text] [Related]
17. Congenital interstitial lung diseases: What the anesthesiologist needs to know.
Bertolizio G; Engelhardt T; Veyckemans F
Paediatr Anaesth; 2022 Feb; 32(2):138-147. PubMed ID: 34738691
[TBL] [Abstract][Full Text] [Related]
18. Persistent Lung Disease in Adults with NKX2.1 Mutation and Familial Neuroendocrine Cell Hyperplasia of Infancy.
Nevel RJ; Garnett ET; Worrell JA; Morton RL; Nogee LM; Blackwell TS; Young LR
Ann Am Thorac Soc; 2016 Aug; 13(8):1299-304. PubMed ID: 27187870
[TBL] [Abstract][Full Text] [Related]
19. French national cohort of neuroendocrine cell hyperplasia of infancy (FRENCHI) study: diagnosis and initial management.
Fabre C; Thumerelle C; Dervaux M; Abou-Taam R; Bihouee T; Brouard J; Clement A; Delacourt C; Delestrain C; Epaud R; Ghdifan S; Hadchouel A; Houdouin V; Labouret G; Perisson C; Reix P; Renoux MC; Troussier F; Weiss L; Mazenq J; Nathan N; Dubus JC
Eur J Pediatr; 2022 Aug; 181(8):3067-3073. PubMed ID: 35678871
[TBL] [Abstract][Full Text] [Related]
20. Ultrastructural characterization of genetic diffuse lung diseases in infants and children: a cohort study and review.
Citti A; Peca D; Petrini S; Cutrera R; Biban P; Haass C; Boldrini R; Danhaive O
Ultrastruct Pathol; 2013 Oct; 37(5):356-65. PubMed ID: 24047351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
